［1］Rebecca L，Siegel Kimberly D，Miller K，et al.Cancer statistics，2018［J］.CA：A Cancer Journal for Clinicians，2018，68(1)：7-30.
［2］Chen W，Zheng R，Baade PD，et al.Cancer statistics in china，2015［J］.CA Cancer J Clin，2016，66(2):115-132.
［3］RJ Gillies，AR Anderson，RA Gatenby，et al.The biology underlying molecular imaging in oncology：from genome to anatome and back again［J］.Clinical Radiology，2010，65(7)：517-521.
［4］LI Shuangshuang，HOU Zhen，LIU Juan，et al.A review of radiomics analysis and modeling tools［J］.Chinese Journal of Medical Physics，2018，35(09)：1043-1049.［李双双，侯震，刘娟等.影像组学分析与建模工具综述［J］.中国医学物理学杂志，2018，35(09)：1043-1049.］
［5］R Wilson，A Devaraj.Radiomics of pulmonary nodules and lung cancer［J］.Translational Lung Cancer Research，2017，6(1)：86-91.
［6］Hu Liping，Wen Qingyi，Liu Lan.The value of MRI dynamic enhancement time-signal curve，diffusion-weighted imaging and incoherent motion in voxels for the diagnosis of breast lesions［J］.Practical Cancer Journal，2018，33(09)：1508-1511.
［7］VS Parekh，MA Jacobs.Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI［J］.NPJ Breast Cancer，2017，14(3)：43.
［8］HM Whitney，NS Taylor，K Drukker，et al.Additive benefit of radiomics over size alone in the distinction between benign lesions and luminal a cancers on a large clinical breast MRI dataset［J］.Academic Radiology，2018，26(2)：202-209.
［9］W Bogner，S Gruber，K Pinker,et al.Diffusion-weighted MR for differentiation of breast lesions at 3.0 T：How does selection of diffusion protocols affect diagnosis［J］?Radiology，2009，253(2)：341-351.
［10］Bickelhaupt S，Jaeger PF，Laun FB，et al.Radiomics based on adapted diffusion kurtosis imaging helps to clarify most mammographic findings suspicious for cancer［J］.Radiology，2018,287(3)：p761-770.
［11］Q Zhang，Y Xiao，J Suo,et al.Sonoelastomics for breast tumor classification：A radiomics approach with clustering-based feature selection on sonoelastography［J］.Ultrasound in Medicine & Biology，2017，43(5)：1058-1069.
［12］Alberto Stefano Tagliafico，Francesca Valdora，Giovanna Mariscotti，et al.An exploratory radiomics analysis on digital breast tomosynthesis in women with mammographically negative dense breasts［J］.The Breast，2018(40)：92-96.
［13］Mao N，Yin P，Wang Q，et al.Added value of radiomics on mammography for breast cancer diagnosis：a feasibility study［J］.J Am Coll Radiol,2019，16（4）：485-491.
［14］Li H，Mendel KR，Lan L，et al.Digital mammography in breast cancer：Additive value of radiomics of breast parenchyma［J］.Radiology,2019，191(1)：15-20.
［15］A Goldhirsch，E Winer，A Coates，et al.Personalizing the treatment of women with early breast cancer：Highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2013［J］.Annals of Oncology，2013，24(9)：2206-2223.
［16］BS Rosenstein，CM West，SM Bentzen，et al.Radiogenomics：Radiobiology enters the era of big data and team science［J］.International Journal of Radiation Oncology Biology Physics，2014，89(4)：709-713.
［17］Hjwl Aerts，Ee Velazquez，Rth Leijenaar，et al.Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach［J］.Nature Communications，2014(5)：4006.
［18］W Guo，H Li，Y Zhu，et al.Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data［J］.Journal of Medical Imaging，2015，2(4)：041007.
［19］M Fan，H Li，Swang，et al.Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer［J］.PLoS One，2017，12(2)：e0171683.
［20］Y Guo，Y Hu，M Qiao,et al.Radiomics analysis on ultrasound for prediction of biologic behavior in breast invasive ductal carcinoma［J］.Clinical Breast Cancer，2018，18(3)：e335-e344.
［21］P Tang，KA Skinner，DG Hicks.Molecular classification of breast carcinomas by immunohistochemical analysis：Are we ready［J］?Diagnostic Molecular Pathology，2009，18(3)：125-132.
［22］L Zhang，YJ Liu，SQ Jiang，et al.Ultrasound utility for predicting biological behavior of invasive ductal breast cancers［J］.Asian Pacific Journal of Cancer Prevention，2014,15(19)：8057-8062.
［23］W Ma，Y Zhao，Y Ji，et al.Breast cancer molecular subtype prediction by mammographic radiomic features［J］.Academic Radiology，2018，26(2)：196-201.
［24］Lidija Antunovic，Francesca Gallivanone，Martina Sollini，et al.［18F］FDG PET/CT features for the molecular characterization of primary breast tumors［J］.Eur J Nucl Med Mol Imaging，2017，44(12)：1545-1554.
［25］S Luangdilok，N Samarnthai，K Korphaisarn.Association between pathological complete response and outcome following neoadjuvant chemotherapy in locally advanced breast cancer patients［J］.Journal of Breast Cancer，2014,17(4)：376-385.
［26］H Earl，E Provenzano，J Abraham，et al.Neoadjuvant trials in early breast cancer：Pathological response at surgery and correlation to longer term outcomes-what does it all mean［J］?BMC Medicine，2015，13(1)：234.
［27］NM Braman，M Etesami，P Prasanna，et al.Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI［J］.Breast Cancer Research，2017，19(1)：57-80.
［28］Lin Zhouyi，Zhang Qunxia，Ran Haitao.Research progress in imaging diagnosis of axillary lymph node metastasis in breast cancer［J］.Chinese Journal of Medical Imaging，2018，26(07)：552-555.
［29］Yuhao Dong，Qianjin Feng，Wei Yang，et al.Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MR［J］.European Radiology,2017，28(2)：582-591.
［30］MJ Ellis，VJ Suman，J Hoog，et al.Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer：Results from the American college of surgeons oncology group Z1031 trial (alliance)［J］.Journal of Clinical Oncology，2017，35（10）：1061-1069.
［31］Seunggyun Ha，Sohyun Park，Ji-In Bang，et al.Metabolic radiomics for pretreatment 18F-FDG PET/CT to characterize locally advanced breast cancer：histopathologic characteristics，response to neoadjuvant chemotherapy，and prognosis［J］.Scientific Report，2017，7(1)：1556.
［32］Tao Wan，B Nicolas Bloch，Donna Plecha，et al.A Radio-genomics approach for identifying high risk estrogen receptor-positive breast cancers on DCE-MRI：Preliminary results in predicting oncotypeDX risk scores［J］.Scientific Report，2016，18(6)：21394.
［33］F Valdora，N Houssami，F Rossi，et al.Rapid review：Radiomics and breast cancer［J］.Breast Cancer Research and Treatment，2018，169(2)：217-229.